OBJECTIVE: To determine the incidence of pancreatitis and pancreatic cancer in the SAVOR-TIMI 53 trial.RESEARCH DESIGN AND METHODS A total of 16,492 type 2 diabetic patients 40 years old with established cardiovascular (CV) disease or CV risk factors were randomized to saxagliptin or placebo and followed for 2.1 years.

READ FULL ARTICLE Curated publisher From Diabetesjournals